// App-Quantinova.ai

5182 : A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics using the tumor marker Rgs16::GFP

Researchers

Presenter

  • Ozhan Ocal

Principal Investigators

  • Victor Pashkov

  • Rahul K. Kollipara

  • James B. Lorens

  • Galvin H. Swift

  • Rolf A. Brekken

  • Thomas M. Wilkie

Medical Centers

  • UTSouthwestern Medical Center, Dallas, TX

  • University of Bergen, Bergen, Norway

Locations

  • United States

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved